Grab pharma picks for healthy run, say analysts
Investing in shares of pharma companies is likely to give good returns in mid-to-long term, analysts say. The markets have been volatile off late, but analysts say pharma sector will outperform as several companies will get a booster shot from lot of top-selling drugs going off-patent in the US.
June 27, 2011 / 15:55 IST
Nachiket Kelkar
Moneycontrol.com
Investing in shares of pharma companies is likely to give good returns in mid-to-long term, analysts say. The markets have been volatile off late, but analysts say pharma sector will outperform as several companies will get a booster shot from lot of top-selling drugs going off-patent in the US.The pharma sector has outperformed the broader markets this year. The NSE
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
